Last observation carry-forward and last observation analysis

Statistics in Medicine

Volumn 22, Issue 15, 2003, Pages 2429-2441

  Shao, Jun ^a   Zhong, Bob ^b  

^a University of Wisconsin Madison   (United States)

^b NeoPharm Inc   (United States)

Author keywords

ANOVA; Informative drop out; Last observation; Post stratification; Size

Indexed keywords

ANTIRHEUMATIC AGENT; BIOLOGICAL PRODUCT;

ANALYSIS OF VARIANCE; ARTICLE; CLINICAL TRIAL; HUMAN; INFORMATION PROCESSING; OBSERVATION; RANDOMIZATION; RHEUMATOID ARTHRITIS; SAMPLE SIZE; SIMULATION; STATISTICAL ANALYSIS; TREATMENT OUTCOME; VALIDATION PROCESS;

ANALYSIS OF VARIANCE; CLINICAL TRIALS; OBSERVATION; PATIENT DROPOUTS; PATIENT PARTICIPATION; PATIENT SELECTION; RESEARCH SUBJECTS; UNITED STATES;

EID: 0041633671     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/sim.1519     Document Type: Article

References (11)

1. Diggle PJ, Liang K-Y, Zeger SL. Analysis of Longitudinal Data. Oxford University Press: Oxford, 1994.
2. Heyting A, Tolboom JTBM, Essers JGA. Statistical handling of drop-outs in longitudinal clinical trials. Statistics in Medicine 1992; 11:2043-2061.
3. FDA. Guideline for Format and Content of the Clinical and Statistical Sections of New Drug Applications. Center for Drug Evaluation and Research, Food and Drug Administration: Rockville, Maryland, 1988.
4. ICH. International Conference on Harmonization. Guidelines on Statistical Principles for Clinical Trials (E9), 1997.
5. Knickerbocker RK. Intention-to-treat analyses. In Encyclopedia of Biopharmaceutical Statistics, Chow S (ed.). Marcel Dekker: New York, 2000; 271-275.
6. Little RJ, Rubin DB. Statistical Analysis with Missing Data. Wiley: New York, 1987.
7. Lavori PW. Clinical trials in psychiatry: Should protocol deviation censor patient data? Neuropsychopharmacology 1992; 6:39-48.
8. Dawson JD. Comparing treatment groups on the basis of slopes, areas-under-the-curve, and other summary measures. Drug Information Journal 1994; 28:723-732.
9. Ting, N. Carry-forward analysis. In Encyclopedia of Biopharmaceutical Statistics, Chow S (ed.). Marcel Dekker: New York, 2001; 103-109.
10. McHugh R. Matts J. Post-stratification in the randomized clinical trial. Biometrics 1983; 39:217-225.
11. Valliant R. Poststratification and conditional variance estimation. Journal of the American Statistical Association 1993; 88:89-96.